OP Asset Management’s Novavax NVAX Stock Holding History

OP Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$597K	Buy	+63,397	New	+$568K	0.01%	646

Other funds holding NVAX

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return

OP Asset Management's NVAX Position: Q2 2026 in Review

OP Asset Management opened a new position in Novavax (NVAX) in Q2 2026: 63,397 shares worth $597K. The stake represents 0.01% of the portfolio and ranks #646 among its holdings.

52 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

OP Asset Management held 63,397 shares of Novavax worth $597K as of Q2 2026.
Novavax was a new OP Asset Management position in Q2 2026.
Novavax made up 0.01% of OP Asset Management's portfolio in Q2 2026, its #646 holding.
52 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.